Antifungal Therapeutics

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.

There are three classes of drugs typically used to treat fungal infections: polyenes, azoles, and echinocandins.

Polyenes

polyenes’ are drugs that work by attaching to the sterol component found in the fungal membrane, causing the cells to become porous and die. The two polyenes most commonly used are nystatin (Mycostatin) and amphotericin B (Fungizone). Nystatin is often used as a topical agent to treat superficial infections, or is taken orally to treat candidal infections such as oral or esophageal candidiasis.

Amphotericin B was the first antifungal drug to be approved for use, and it is still the standard therapy for the most severe systemic fungal infections. Recently, several new types of amphotericin B (Abelcet, Amphotec and AmBisome) have been introduced. These drugs, called lipid formulations, cause fewer side effects than traditional amphotericin B but are more expensive.

Azoles

Azoles stop fungal growth by preventing fungi from making an essential part of their cell wall. Three typical azoles are ketoconazole (Nizoral), fluconazole (Diflucan), and itraconazole (Sporanox). Ketoconazole is the oldest of these three drugs, and has been used since the 1970s. It is slightly more toxic than the other azoles and does not work for aspergillosis and many candidiasis infections.

Although fluconazole is effective against both superficial and systemic candidiasis, some strains of this fungus have now become resistant to the drug. Itraconazole, the newest of the azoles, is effective against a range of different fungal infections. Unlike ketoconazole or fluconazole, it can be used to treat aspergillosis.

Echinocandins

Echinocandins are a new class of antifungal drugs that work by disrupting the wall that surrounds fungal cells. Caspofungin (Cancidas) is the first of this new class of drugs to be approved. It is an effective treatment for severe, systemic fungal infections, and is given to patients who do not respond to other therapies.

  • Mycostatin
  • Esophageal candidiasis
  • Caspofungin

Related Conference of Antifungal Therapeutics

October 26-28, 2017

8th Clinical Microbiology Conference

Paris, France
November 29-December 01, 2017

4th World Congress and Expo on Applied Microbiology

Madrid, Spain
July 02-04, 2018

10th International Virology Congress and Expo

Vienna, Austria
February 22-23, 2018

8th Global Summit on Microbiology & Infectious Diseases

Paris, France
June 28-29, 2018

11th Annual Medical Microbiology Summit & Expo

Amsterdam, Netherlands
July 11-12, 2018

2nd International Conference on Microbial Ecology & Eco Systems

Toronto, Ontario, Canada
(10 Plenary Forums 2 days 1 event)
July 11-12, 2018

7th International conference on Environmental Microbiology & Soil Microbiology

Toronto, Ontario, Canada
(10 Plenary Forums 2 days 1 event)
July 16-18, 2018 London, UK

Microbialphysiology 2018

September 10-11, 2018

47th World Congress on Microbiology

London, UK
(9 Plenary forums, 2 days, 1 event)
December 05-06, 2018

8th Annual Congress on Clinical Microbiology

Toronto, Ontario, Canada

Antifungal Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in